医学
食品药品监督管理局
不利影响
肥胖
药品
减肥
重症监护医学
药理学
内科学
作者
Homayoun L. Daneschvar,Mark D. Aronson,Gerald W. Smetana
标识
DOI:10.1016/j.amjmed.2016.02.009
摘要
Obesity is a growing health problem in our society and its treatment has been challenging. In recent decades, several anti-obesity drugs have been withdrawn from the market because of reported and documented adverse effects. After years of interruption, the US Food and Drug Administration (FDA) has recently approved multiple new anti-obesity drugs. The majority of these medications are taken orally, and only one is administered subcutaneously. In this article, we review the efficacy, adverse effects, and mechanism of action of all 5 FDA-approved drugs.
科研通智能强力驱动
Strongly Powered by AbleSci AI